Pharma Struggling To Assimilate Flood Of Clinical Trial Data
Big data may be prolonging development times for new pharmaceuticals, as companies struggle to cope with diverse digital applications and clinical trial protocol changes.
You may also be interested in...
This past year was a busy one for regulators and regulated alike in the EU. We take a look at some of the key events from 2017.
The great and good of the pharmaceutical industry have again been speaking about the big opportunities that big data provides, but senior executives from IBM Watson Health and Formula 1 giant McLaren believe the sector should be doing more.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.